Terms: = Cervical cancer AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839 AND Prognosis
2 results:
1. A Novel Prognostic Risk Model for cervical cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract] [Full Text] [Related]
2. The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for cervical cancer.
Nishida T; Nakamura K; Haraga J; Ogawa C; Kusumoto T; Seki N; Masuyama H; Katayama N; Kanazawa S; Hiramatsu Y
Int J Gynecol Cancer; 2015 Sep; 25(7):1306-14. PubMed ID: 26067860
[TBL] [Abstract] [Full Text] [Related]
